{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:43:29Z","timestamp":1761835409315,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.tranon.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T11:47:54Z","timestamp":1577706474000},"page":"393-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model"],"prefix":"10.1016","volume":"13","author":[{"given":"Kentaro","family":"Igarashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Kiyuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuyo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Dry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shree Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00000658-194603000-00011","article-title":"Rhabdomyosarcoma of the skeletal muscles","volume":"123","author":"Stout","year":"1946","journal-title":"Ann Surg"},{"key":"10.1016\/j.tranon.2019.10.005_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.4-1-34","article-title":"Rhabdomyosarcoma: an overview","volume":"4","author":"Dagher","year":"1999","journal-title":"The Oncologist"},{"key":"10.1016\/j.tranon.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2019.10.005_bib4","first-page":"106","article-title":"Cancer statistics","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tranon.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cncr.10669","article-title":"Adult rhabdomyosarcoma: outcome following multimodality treatment","volume":"95","author":"Little","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/modpathol.3880357","article-title":"Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers","volume":"14","author":"Furlong","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.tranon.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00043426-200105000-00008","article-title":"Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V","volume":"23","author":"Raney","year":"2001","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.tranon.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13577140120048890","article-title":"The intergroup rhabdomyosarcoma study group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols","volume":"5","author":"Raney","year":"2001","journal-title":"Sarcoma"},{"key":"10.1016\/j.tranon.2019.10.005_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/pbc.10441","article-title":"Age is an independent prognostic factor in rhabdomyosarcoma: a report from the soft tissue sarcoma Committee of the Children's Oncology Group","volume":"42","author":"Joshi","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tranon.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The third intergroup rhabdomyosarcoma study","volume":"13","author":"Crist","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tranon.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000658-200108000-00012","article-title":"Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma","volume":"234","author":"Esnaola","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.tranon.2019.10.005_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q","article-title":"Clinicopathologic analysis of patients with adult rhabdomyosarcoma","volume":"91","author":"Hawkins","year":"2001","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrc3972","article-title":"Patient-derived orthotopic xenografts: better mimic\u00a0of\u00a0metastasis than subcutaneous xenografts","volume":"15","author":"Hoffman","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/15384101.2016.1252885","article-title":"Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model","volume":"16","author":"Igarashi","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2019.10.005_bib15","first-page":"1","article-title":"Coffee, tea, mate, methylxanthines and methylglyoxal, IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 27 February to 6 March 1990","volume":"51","year":"1991","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.tranon.2019.10.005_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000210963","article-title":"Xanthines inhibit 3T3 fibroblast proliferation","volume":"4","author":"Levi-Schaffer","year":"1991","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.tranon.2019.10.005_bib17","first-page":"4396","article-title":"Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways","volume":"63","author":"He","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2307\/3574633","article-title":"The action of caffeine on x-irradiated Hela cells. I. Delayedinhibition of DNA synthesis","volume":"71","author":"Tolmach","year":"1977","journal-title":"Radiat Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1073\/pnas.79.9.2942","article-title":"Mechanism by which caffeine potentiates lethality of nitrogen mustard","volume":"79","author":"Lau","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tranon.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/jcb.24593","article-title":"Dynamic color-coded fluorescence imaging of the cell-cycle phase, mitosis, and apoptosis demonstrates how caffeine modulates cisplatinum efficacy","volume":"114","author":"Miwa","year":"2013","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.tranon.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","article-title":"The clinical development of histone deacetylase inhibitors as targeted anticancer drugs","volume":"19","author":"Marks","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.tranon.2019.10.005_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18632\/oncotarget.106","article-title":"Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome","volume":"1","author":"Raffoux","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.bjc.6604817","article-title":"A\u00a0phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma","volume":"100","author":"Rocca","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tranon.2019.10.005_bib24","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-08-1930","article-title":"Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I\/II trial of valproic acid and epirubicin\/FEC","volume":"15","author":"Munster","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.tranon.2019.10.005_bib25","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.21873\/anticanres.10992","article-title":"Non-toxic efficacy of the combination of caffeine and valproic acid on human osteosarcoma cells in Vitro and in orthotopic nude-mouse models","volume":"36","author":"Igarashi","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib26","doi-asserted-by":"crossref","first-page":"12783","DOI":"10.18632\/oncotarget.7226","article-title":"Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model","volume":"7","author":"Murakami","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tranon.2019.10.005_bib28","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1073\/pnas.0703867104","article-title":"Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer","volume":"104","author":"Zhao","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tranon.2019.10.005_bib29","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-06-0716","article-title":"Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice","volume":"66","author":"Zhao","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib30","first-page":"2501","article-title":"Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice","volume":"32","author":"Zhang","year":"2012","journal-title":"Anticancer Res"},{"year":"2005","series-title":"CompuSyn for drug combinations: PC\u00a0software and user's guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of\u00a0IC50 and ED50 and LD50 values","author":"Chou","key":"10.1016\/j.tranon.2019.10.005_bib31"},{"key":"10.1016\/j.tranon.2019.10.005_bib32","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.18632\/oncotarget.2811","article-title":"Tumor targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib33","first-page":"4331","article-title":"Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice","volume":"32","author":"Uchugonova","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21873\/anticanres.13082","article-title":"Detection of metastasis in a patient-derived orthotopic xenograft (PDOX) model of undifferentiated pleomorphic sarcoma with red fluorescent protein","volume":"39","author":"Oshiro","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tranon.2019.10.005_bib35","doi-asserted-by":"crossref","first-page":"62111","DOI":"10.18632\/oncotarget.19095","article-title":"A\u00a0patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology","volume":"8","author":"Igarashi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/1061186X.2018.1499748","article-title":"Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated\/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models","volume":"27","author":"Kawaguchi","year":"2019","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.tranon.2019.10.005_bib37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbrc.2018.09.106","article-title":"A\u00a0combination of irinotecan\/cisplatinum and irinotecan\/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model","volume":"505","author":"Kiyuna","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tranon.2019.10.005_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tice.2018.05.010","article-title":"Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model","volume":"53","author":"Kiyuna","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.tranon.2019.10.005_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopha.2018.12.110","article-title":"The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model","volume":"111","author":"Higuchi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tranon.2019.10.005_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbrc.2019.01.046","article-title":"Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model","volume":"509","author":"Miyake","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tranon.2019.10.005_bib41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2019.03.003","article-title":"Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model","volume":"451","author":"Higuchi","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.tranon.2019.10.005_bib42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00280-019-03782-w","article-title":"Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model","volume":"83","author":"Miyake","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.tranon.2019.10.005_bib43","doi-asserted-by":"crossref","first-page":"63353","DOI":"10.18632\/oncotarget.18806","article-title":"A\u00a0novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)","volume":"8","author":"Igarashi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib44","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15384101.2017.1317417","article-title":"Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model","volume":"16","author":"Igarashi","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2019.10.005_bib45","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/15384101.2017.1304340","article-title":"The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago","volume":"16","author":"Murakami","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2019.10.005_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bbrc.2018.02.174","article-title":"Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models","volume":"497","author":"Igarashi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tranon.2019.10.005_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/15384101.2018.1431596","volume":"17","author":"Igarashi","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2019.10.005_bib48","doi-asserted-by":"crossref","first-page":"e00643","DOI":"10.1016\/j.heliyon.2018.e00643","article-title":"Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations","volume":"4","author":"Miyake","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.tranon.2019.10.005_bib49","doi-asserted-by":"crossref","first-page":"103129","DOI":"10.18632\/oncotarget.20789","article-title":"The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing's sarcoma with a FUS-ERG fusion and CDKN2A deletion: direction for third-line patient therapy","volume":"8","author":"Miyake","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2019.10.005_bib50","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.2005.03.7689","article-title":"Cyclin-dependent kinase pathways as targets for cancer treatment","volume":"24","author":"Shapiro","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tranon.2019.10.005_bib51","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4161\/cc.5.18.3218","article-title":"Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human","volume":"5","author":"Lee","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tranon.2019.10.005_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00165-X","article-title":"Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?","volume":"4","author":"Johnstone","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2019.10.005_bib53","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4161\/15384101.2014.964115","article-title":"Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy","volume":"13","author":"Yano","year":"2014","journal-title":"Cell Cycle"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523319305030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523319305030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:39:13Z","timestamp":1761835153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523319305030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1936523319305030"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2019.10.005","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}